Shares of P3 Health Partners were trading at $0.1829 as of March 25. Over the last 52-week period, shares are down 82.58%.

P3 Health Partners' Q4 2024 earnings show 18% annual revenue growth and reaffirmed profitability goals for 2025.

Good day and welcome to the P3 Health Partners’ Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there ...

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago. These ...

HENDERSON, Nev., March 13, 2025--(BUSINESS WIRE)--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the ...

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial ...

HENDERSON, Nev., March 13, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to ...

P3 Health Partners Inc. (PIII) reported Q3 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $248.3 million versus the consensus... Investing.com ...